Frontlight ResearchEarly access
Active, not recruitingNo phase
Kaneka Endovascular Embolization and Protection
Key facts
- Who runs it
- Kaneka Medical America LLC
- Where
- Cleveland, Grand Blanc, New York, and Oklahoma City, United StatesSee the 4 sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 164 people, planned
- Started
- 13 Dec 2022
- Ended
- Dec 2025
- Type of study
- Interventional
- Treatments tested
- i-ED COIL
- Record updated
- 7 October 2025
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (9)Hide the full registry criteria
Who can take part
- Target aneurysm of 4mm - 14mm in size
- Ruptured or unruptured
- Suitable for embolization with coils
- May be treated with or without assist devices
Who cannot take part
- Unstable neurological deficit in unruptured cases (condition worsening within last 90 days)
- Evidence of active infection (e.g.,fever, temperature >38 degrees C and/or WBC >15,000)
- Pre-planned staged procedure of target aneurysm
- mRS score 3 or more
- Hunt Hess Score more than 3 for subjects with ruptured aneurysm
Where in United States
- Cleveland ClinicCleveland, United States
- McLaren Health CareGrand Blanc, United States
- Northwell Health- Lenox Hill HospitalNew York, United States
- SSM Health St. Anthony's HospitalOklahoma City, United States
About the trial
What the trial wants to find out
Prospective, multi-center, non-randomized registry / study, up to 164 patients enrolled and followed at 180 days +/- 45 days and again at 365 days +/- 90 days post procedure
The group in the trial
- Interventional treatmentOther group
Open label
Treatment: i-ED COIL
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 7 October 2025